Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald B Kohn

Showing results (171-180 of 273) with videos related to

Pageof 28
Sort By:
Blood|January 9, 2019
Anti-human CD117 antibody-mediated bone marrow niche clearance in nonhuman primates and humanized NSG miceHye-Sook Kwon, Aaron C Logan, Akanksha Chhabra, et al.
Cytotherapy|July 23, 2017
Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell diseaseFabrizia Urbinati, Jennifer Wherley, Sabine Geiger, et al.
Stem Cells (Dayton, Ohio)|March 29, 2014
Erythropoiesis from human embryonic stem cells through erythropoietin-independent AKT signalingWilliam S Kim, Yuhua Zhu, Qiming Deng, et al.
Annals of the New York Academy of Sciences|June 12, 2003
Efficient characterization of retro-, lenti-, and foamyvector-transduced cell populations by high-accuracy insertion site sequencingManfred Schmidt, Hanno Glimm, Manuela Wissler, et al.
Blood|July 5, 2011
Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiencyRobert Sokolic, Irina Maric, Chimene Kesserwan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2013
Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cellsFrancesca Giannoni, Cinnamon L Hardee, Jennifer Wherley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2002
Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cellsMary A Price, Scott S Case, Denise A Carbonaro, et al.
Experimental Hematology|March 18, 2006
Effects of busulfan dose escalation on engraftment of infant rhesus monkey hematopoietic stem cells after gene marking by a lentiviral vectorChristoph A Kahl, Alice F Tarantal, Chang I Lee, et al.
Stem Cells (Dayton, Ohio)|October 30, 2018
Improving Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells by Temporal Control of DNA RepairAnastasia Lomova, Danielle N Clark, Beatriz Campo-Fernandez, et al.
Frontiers in Genome Editing|October 29, 2021
Global and Local Manipulation of DNA Repair Mechanisms to Alter Site-Specific Gene Editing Outcomes in Hematopoietic Stem CellsElizabeth K Benitez, Anastasia Lomova Kaufman, Lilibeth Cervantes, et al.
Pageof 28

Showing results (171-180 of 273) with videos related to

Sort By:
Pageof 28
Blood|January 9, 2019
Anti-human CD117 antibody-mediated bone marrow niche clearance in nonhuman primates and humanized NSG miceHye-Sook Kwon, Aaron C Logan, Akanksha Chhabra, et al.
Cytotherapy|July 23, 2017
Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell diseaseFabrizia Urbinati, Jennifer Wherley, Sabine Geiger, et al.
Stem Cells (Dayton, Ohio)|March 29, 2014
Erythropoiesis from human embryonic stem cells through erythropoietin-independent AKT signalingWilliam S Kim, Yuhua Zhu, Qiming Deng, et al.
Annals of the New York Academy of Sciences|June 12, 2003
Efficient characterization of retro-, lenti-, and foamyvector-transduced cell populations by high-accuracy insertion site sequencingManfred Schmidt, Hanno Glimm, Manuela Wissler, et al.
Blood|July 5, 2011
Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiencyRobert Sokolic, Irina Maric, Chimene Kesserwan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2013
Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cellsFrancesca Giannoni, Cinnamon L Hardee, Jennifer Wherley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2002
Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cellsMary A Price, Scott S Case, Denise A Carbonaro, et al.
Experimental Hematology|March 18, 2006
Effects of busulfan dose escalation on engraftment of infant rhesus monkey hematopoietic stem cells after gene marking by a lentiviral vectorChristoph A Kahl, Alice F Tarantal, Chang I Lee, et al.
Stem Cells (Dayton, Ohio)|October 30, 2018
Improving Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells by Temporal Control of DNA RepairAnastasia Lomova, Danielle N Clark, Beatriz Campo-Fernandez, et al.
Frontiers in Genome Editing|October 29, 2021
Global and Local Manipulation of DNA Repair Mechanisms to Alter Site-Specific Gene Editing Outcomes in Hematopoietic Stem CellsElizabeth K Benitez, Anastasia Lomova Kaufman, Lilibeth Cervantes, et al.
Pageof 28